Innovative Antibody Chimeras Transform Cancer Immunotherapy
Kilder
- Nature: Antibody-lectin chimeras for glyco-immune checkpoint blockade - Nature
- Nature: A pooled Cell Painting CRISPR screening platform enables de novo inference of gene function by self-supervised deep learning - Nature
- Nature: Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry - Nature
- Statnews: FDA initiates priority voucher for J&J’s ‘Tec-Dara’ combo - statnews.com
- Fiercebiotech: Aldeyra dry eye disease candidate hit by FDA delay amid shifting agency guidance, biotech says - Fierce Biotech
- Biopharmadive: Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study - BioPharma Dive
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.